These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 19730774)
1. Long-term survivors of glioblastoma: clinical features and molecular analysis. Sonoda Y; Kumabe T; Watanabe M; Nakazato Y; Inoue T; Kanamori M; Tominaga T Acta Neurochir (Wien); 2009 Nov; 151(11):1349-58. PubMed ID: 19730774 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients. Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival with glioblastoma multiforme. Krex D; Klink B; Hartmann C; von Deimling A; Pietsch T; Simon M; Sabel M; Steinbach JP; Heese O; Reifenberger G; Weller M; Schackert G; Brain; 2007 Oct; 130(Pt 10):2596-606. PubMed ID: 17785346 [TBL] [Abstract][Full Text] [Related]
4. Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin. Park CK; Park SH; Lee SH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW Neuropathology; 2009 Aug; 29(4):443-9. PubMed ID: 19170894 [TBL] [Abstract][Full Text] [Related]
5. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma. Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111 [TBL] [Abstract][Full Text] [Related]
6. Association between response to primary treatments and MGMT status in glioblastoma. Franceschi E; Tosoni A; Pozzati E; Brandes AA Expert Rev Anticancer Ther; 2008 Nov; 8(11):1781-6. PubMed ID: 18983238 [TBL] [Abstract][Full Text] [Related]
7. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas. Yachi K; Watanabe T; Ohta T; Fukushima T; Yoshino A; Ogino A; Katayama Y; Nagase H Int J Oncol; 2008 Sep; 33(3):469-75. PubMed ID: 18695875 [TBL] [Abstract][Full Text] [Related]
8. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Hartmann C; Hentschel B; Simon M; Westphal M; Schackert G; Tonn JC; Loeffler M; Reifenberger G; Pietsch T; von Deimling A; Weller M; Clin Cancer Res; 2013 Sep; 19(18):5146-57. PubMed ID: 23918605 [TBL] [Abstract][Full Text] [Related]
10. [Glioblastomas: clinical study and search for prognostic factors]. Mineo JF; Quintin-Roue I; Lucas B; Buburusan V; Besson G Neurochirurgie; 2002 Dec; 48(6):500-9. PubMed ID: 12595806 [TBL] [Abstract][Full Text] [Related]
11. Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive Cohort. Nakagawa Y; Sasaki H; Ohara K; Ezaki T; Toda M; Ohira T; Kawase T; Yoshida K World Neurosurg; 2017 Oct; 106():165-173. PubMed ID: 28666913 [TBL] [Abstract][Full Text] [Related]
12. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26). Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083 [TBL] [Abstract][Full Text] [Related]
13. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases. Lutterbach J; Bartelt S; Momm F; Becker G; Frommhold H; Ostertag C Cancer; 2005 Mar; 103(6):1234-44. PubMed ID: 15666327 [TBL] [Abstract][Full Text] [Related]
14. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience. Schlosser S; Wagner S; Mühlisch J; Hasselblatt M; Gerss J; Wolff JE; Frühwald MC Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma. Odrazka K; Petera J; Kohlova T; Dolezel M; Vaculikova M; Zouhar M; Malek V; Hobza V; Latr I; Nemecek S; Sercl M; Ryska P; Blaha M; Cermakova E Strahlenther Onkol; 2003 Sep; 179(9):615-9. PubMed ID: 14628127 [TBL] [Abstract][Full Text] [Related]
16. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. De Schutter H; Geeraerts H; Verbeken E; Nuyts S Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
18. A review of the treatment and survival rates of 138 patients with glioblastoma multiforme. Jubelirer SJ W V Med J; 1996; 92(4):186-90. PubMed ID: 8772403 [TBL] [Abstract][Full Text] [Related]
19. Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy. Patwardhan RV; Shorter C; Willis BK; Reddy P; Smith D; Caldito GC; Nanda A Surg Neurol; 2004 Sep; 62(3):207-13; discussion 214-5. PubMed ID: 15336860 [TBL] [Abstract][Full Text] [Related]
20. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? McLendon RE; Halperin EC Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]